Analysis of the clinical phenotypes of Charcot-Marie-Tooth disease type 2A2 patients with mitofusin2 mutation

Xiaohui Duan, Weihong Gu, Christopher J. Klein, Ying Hao, Guoxiang Wang, Renbin Wang, Dongsheng Fan

Research output: Contribution to journalArticlepeer-review


Objective: To investigate the characteristics of mitofusin2 (MFN2) mutation and the clinical variability of Charcot-Marie-Tooth disease type 2 (CMT2) patients. Methods: MFN2 mutation analysis were performed in 8 autosomal dominant CMT2 families and 24 sporadic CMT2 cases by PCR and direct sequencing. The clinical features of the positive cases were precisely analyzed. Results: Sequencing of the MFN2 gene revealed 4 different missense mutations, and detection rate was 4 of 32 (12.5%) in patients with CMT2. c. 281G≤A (R94Q) and c. 2240 T≤C (M747T) were detected in 2 autosomal dominant pedigrees, and intrafamilial clinical phenotype variability was present; c. 1090 C≤T (R364W)and c. 2198 T≤C (1.733P) were detected in 2 sporadic cases, and the latter was a novel mutation which had not been reported. In addition to weakness and atrophy in the distal limbs, the former sporadic case was optic atrophy, and the latter case was hyperkeratosis of the skin. Conclusions: Divergent MFN2 mutations are frequently found among axonal varieties of CMT2 in the Chinese population, and analysis of phenotypes in the CMT2A2 patients indicate the high clinical variability of this disease.

Original languageEnglish (US)
Pages (from-to)77-83
Number of pages7
JournalChinese Journal of Neurology
Issue number2
StatePublished - Feb 2014


  • Charcot-Marie-Tooth disease
  • Mitochondrial proteins
  • Mutation
  • Phenotype

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Analysis of the clinical phenotypes of Charcot-Marie-Tooth disease type 2A2 patients with mitofusin2 mutation'. Together they form a unique fingerprint.

Cite this